
Butterfly Network, Inc. (NYSE: BFLY) Stock Competitors & Peer Comparison
See BFLY's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BFLY and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BFLY | $7.36 | +0.96% | 2B | -30.67 | -$0.24 | N/A |
| ABT | $108.33 | -0.42% | 187.4B | 20.79 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $94.17 | +1.15% | 120.5B | 17.03 | $5.53 | +3.02% |
| SYK | $303.13 | -1.58% | 116.2B | 22.64 | $13.39 | +1.14% |
| BSX | $47.80 | +1.81% | 71.1B | 15.42 | $3.10 | N/A |
| EW | $89.90 | +0.13% | 51.8B | 33.29 | $2.70 | N/A |
| DXCM | $87.90 | -2.02% | 33.2B | 34.47 | $2.55 | N/A |
| GEHC | $68.86 | -1.23% | 31.1B | 15.10 | $4.56 | +0.20% |
| PHG | $25.89 | -0.61% | 25.3B | 14.79 | $1.75 | +3.82% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
BFLY vs ABT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ABT has a market cap of 187.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ABT trades at $108.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ABT's P/E ratio is 20.79. In terms of profitability, BFLY's ROE is -0.38%, compared to ABT's ROE of +0.11%. Regarding short-term risk, BFLY is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
BFLY vs BSX-PA Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, BFLY's ROE is -0.38%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, BFLY is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
BFLY vs MDT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, MDT has a market cap of 120.5B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while MDT trades at $94.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas MDT's P/E ratio is 17.03. In terms of profitability, BFLY's ROE is -0.38%, compared to MDT's ROE of +0.11%. Regarding short-term risk, BFLY is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
BFLY vs SYK Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SYK has a market cap of 116.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SYK trades at $303.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SYK's P/E ratio is 22.64. In terms of profitability, BFLY's ROE is -0.38%, compared to SYK's ROE of +0.16%. Regarding short-term risk, BFLY is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
BFLY vs BSX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BSX has a market cap of 71.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BSX trades at $47.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BSX's P/E ratio is 15.42. In terms of profitability, BFLY's ROE is -0.38%, compared to BSX's ROE of +0.15%. Regarding short-term risk, BFLY is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
BFLY vs EW Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, EW has a market cap of 51.8B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while EW trades at $89.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas EW's P/E ratio is 33.29. In terms of profitability, BFLY's ROE is -0.38%, compared to EW's ROE of +0.10%. Regarding short-term risk, BFLY is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
BFLY vs DXCM Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, DXCM has a market cap of 33.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while DXCM trades at $87.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas DXCM's P/E ratio is 34.47. In terms of profitability, BFLY's ROE is -0.38%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, BFLY is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
BFLY vs GEHC Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, GEHC has a market cap of 31.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while GEHC trades at $68.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas GEHC's P/E ratio is 15.10. In terms of profitability, BFLY's ROE is -0.38%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, BFLY is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
BFLY vs PHG Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PHG has a market cap of 25.3B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PHG trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PHG's P/E ratio is 14.79. In terms of profitability, BFLY's ROE is -0.38%, compared to PHG's ROE of +0.10%. Regarding short-term risk, BFLY is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
BFLY vs ZBH Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ZBH has a market cap of 19B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ZBH trades at $98.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ZBH's P/E ratio is 11.56. In terms of profitability, BFLY's ROE is -0.38%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, BFLY is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
BFLY vs ABMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ABMD's P/E ratio is 65.36. In terms of profitability, BFLY's ROE is -0.38%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, BFLY is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
BFLY vs PEN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PEN trades at $322.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PEN's P/E ratio is 84.16. In terms of profitability, BFLY's ROE is -0.38%, compared to PEN's ROE of +0.11%. Regarding short-term risk, BFLY is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
BFLY vs SWAV Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SWAV's P/E ratio is 78.76. In terms of profitability, BFLY's ROE is -0.38%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, BFLY is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
BFLY vs SNN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SNN has a market cap of 12.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SNN trades at $28.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SNN's P/E ratio is 13.58. In terms of profitability, BFLY's ROE is -0.38%, compared to SNN's ROE of +0.12%. Regarding short-term risk, BFLY is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
BFLY vs ALGN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ALGN trades at $158.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ALGN's P/E ratio is 14.46. In terms of profitability, BFLY's ROE is -0.38%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, BFLY is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
BFLY vs GMED Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while GMED trades at $78.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas GMED's P/E ratio is 17.63. In terms of profitability, BFLY's ROE is -0.38%, compared to GMED's ROE of +0.12%. Regarding short-term risk, BFLY is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
BFLY vs GKOS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, GKOS has a market cap of 10.5B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while GKOS trades at $177.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas GKOS's P/E ratio is -206.37. In terms of profitability, BFLY's ROE is -0.38%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, BFLY is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
BFLY vs BIO-B Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, BFLY's ROE is -0.38%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, BFLY is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
BFLY vs BIO Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BIO trades at $386.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BIO's P/E ratio is 41.65. In terms of profitability, BFLY's ROE is -0.38%, compared to BIO's ROE of +0.03%. Regarding short-term risk, BFLY is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
BFLY vs PODD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PODD trades at $147.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PODD's P/E ratio is 25.12. In terms of profitability, BFLY's ROE is -0.38%, compared to PODD's ROE of +0.27%. Regarding short-term risk, BFLY is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
BFLY vs MASI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas MASI's P/E ratio is 44.43. In terms of profitability, BFLY's ROE is -0.38%, compared to MASI's ROE of +0.09%. Regarding short-term risk, BFLY is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
BFLY vs BRKR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BRKR trades at $58.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BRKR's P/E ratio is 29.40. In terms of profitability, BFLY's ROE is -0.38%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, BFLY is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
BFLY vs BRKRP Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BRKRP trades at $431.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BRKRP's P/E ratio is 234.13. In terms of profitability, BFLY's ROE is -0.38%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, BFLY is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
BFLY vs NARI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NARI's P/E ratio is -59.24. In terms of profitability, BFLY's ROE is -0.38%, compared to NARI's ROE of -0.00%. Regarding short-term risk, BFLY is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
BFLY vs HAE Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while HAE trades at $102.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas HAE's P/E ratio is 20.54. In terms of profitability, BFLY's ROE is -0.38%, compared to HAE's ROE of +0.11%. Regarding short-term risk, BFLY is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
BFLY vs LIVN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while LIVN trades at $81.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas LIVN's P/E ratio is 19.46. In terms of profitability, BFLY's ROE is -0.38%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, BFLY is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
BFLY vs ITGR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ITGR trades at $126.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ITGR's P/E ratio is 19.76. In terms of profitability, BFLY's ROE is -0.38%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, BFLY is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
BFLY vs IRTC Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while IRTC trades at $123.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas IRTC's P/E ratio is -287.05. In terms of profitability, BFLY's ROE is -0.38%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, BFLY is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
BFLY vs AXNX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AXNX's P/E ratio is -709.80. In terms of profitability, BFLY's ROE is -0.38%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, BFLY is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
BFLY vs TMDX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while TMDX trades at $89.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas TMDX's P/E ratio is 45.68. In terms of profitability, BFLY's ROE is -0.38%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, BFLY is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
BFLY vs AXGN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AXGN trades at $48.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AXGN's P/E ratio is 127.05. In terms of profitability, BFLY's ROE is -0.38%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, BFLY is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
BFLY vs NEOG Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NEOG trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NEOG's P/E ratio is 42.25. In terms of profitability, BFLY's ROE is -0.38%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, BFLY is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
BFLY vs UFPT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while UFPT trades at $288.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas UFPT's P/E ratio is 29.50. In terms of profitability, BFLY's ROE is -0.38%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, BFLY is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
BFLY vs ESTA Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ESTA trades at $74.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ESTA's P/E ratio is -58.96. In terms of profitability, BFLY's ROE is -0.38%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, BFLY is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
BFLY vs NVCR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NVCR trades at $17.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NVCR's P/E ratio is -13.80. In terms of profitability, BFLY's ROE is -0.38%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, BFLY is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check NVCR's competition here
NuVasive, Inc. (NASDAQ: NUVA)
BFLY vs NUVA Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NUVA's P/E ratio is 75.00. In terms of profitability, BFLY's ROE is -0.38%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, BFLY is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
BFLY vs INSP Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while INSP trades at $63.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas INSP's P/E ratio is 27.76. In terms of profitability, BFLY's ROE is -0.38%, compared to INSP's ROE of +0.18%. Regarding short-term risk, BFLY is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
BFLY vs CNMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CNMD trades at $49.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CNMD's P/E ratio is 10.84. In terms of profitability, BFLY's ROE is -0.38%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, BFLY is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
BFLY vs ATEC Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ATEC trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ATEC's P/E ratio is -157.50. In terms of profitability, BFLY's ROE is -0.38%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, BFLY is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check ATEC's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
BFLY vs TNDM Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while TNDM trades at $19.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas TNDM's P/E ratio is -21.40. In terms of profitability, BFLY's ROE is -0.38%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, BFLY is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
BFLY vs HSKA Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas HSKA's P/E ratio is -62.49. In terms of profitability, BFLY's ROE is -0.38%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, BFLY is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
BFLY vs IART Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while IART trades at $16.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas IART's P/E ratio is 7.08. In terms of profitability, BFLY's ROE is -0.38%, compared to IART's ROE of -0.01%. Regarding short-term risk, BFLY is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check IART's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
BFLY vs PRCT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PRCT trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PRCT's P/E ratio is -11.73. In terms of profitability, BFLY's ROE is -0.38%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, BFLY is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check PRCT's competition here
Artivion, Inc. (NYSE: AORT)
BFLY vs AORT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AORT trades at $25.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AORT's P/E ratio is 42.63. In terms of profitability, BFLY's ROE is -0.38%, compared to AORT's ROE of -0.01%. Regarding short-term risk, BFLY is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check AORT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
BFLY vs AVNS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AVNS's P/E ratio is 27.77. In terms of profitability, BFLY's ROE is -0.38%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, BFLY is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
BFLY vs LMRI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, LMRI has a market cap of 1.2B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while LMRI trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas LMRI's P/E ratio is -23.70. In terms of profitability, BFLY's ROE is -0.38%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, BFLY is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
BFLY vs SILK Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SILK's P/E ratio is -18.96. In terms of profitability, BFLY's ROE is -0.38%, compared to SILK's ROE of -0.35%. Regarding short-term risk, BFLY is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
BFLY vs IRMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while IRMD trades at $83.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas IRMD's P/E ratio is 43.51. In terms of profitability, BFLY's ROE is -0.38%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, BFLY is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
BFLY vs FNA Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas FNA's P/E ratio is -19.83. In terms of profitability, BFLY's ROE is -0.38%, compared to FNA's ROE of -0.35%. Regarding short-term risk, BFLY is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
BFLY vs ENOV Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ENOV trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ENOV's P/E ratio is 5.31. In terms of profitability, BFLY's ROE is -0.38%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, BFLY is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check ENOV's competition here
Bioventus Inc. (NASDAQ: BVS)
BFLY vs BVS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BVS has a market cap of 953.2M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BVS trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BVS's P/E ratio is 18.51. In terms of profitability, BFLY's ROE is -0.38%, compared to BVS's ROE of +0.28%. Regarding short-term risk, BFLY is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
BFLY vs CBLL Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CBLL has a market cap of 937.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CBLL trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CBLL's P/E ratio is -14.05. In terms of profitability, BFLY's ROE is -0.38%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, BFLY is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CBLL's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
BFLY vs AHCO Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AHCO has a market cap of 883M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AHCO trades at $6.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AHCO's P/E ratio is 13.24. In terms of profitability, BFLY's ROE is -0.38%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, BFLY is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check AHCO's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
BFLY vs AVR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, AVR has a market cap of 879M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while AVR trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas AVR's P/E ratio is -4.66. In terms of profitability, BFLY's ROE is -0.38%, compared to AVR's ROE of -0.78%. Regarding short-term risk, BFLY is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check AVR's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
BFLY vs BBNX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BBNX has a market cap of 873.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BBNX trades at $19.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BBNX's P/E ratio is -11.77. In terms of profitability, BFLY's ROE is -0.38%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, BFLY is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
BFLY vs INMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, INMD has a market cap of 857M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while INMD trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas INMD's P/E ratio is 10.35. In terms of profitability, BFLY's ROE is -0.38%, compared to INMD's ROE of +0.12%. Regarding short-term risk, BFLY is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
BFLY vs CSII Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CSII's P/E ratio is -20.83. In terms of profitability, BFLY's ROE is -0.38%, compared to CSII's ROE of -0.14%. Regarding short-term risk, BFLY is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
BFLY vs SIBN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SIBN has a market cap of 820.5M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SIBN trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SIBN's P/E ratio is -54.41. In terms of profitability, BFLY's ROE is -0.38%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, BFLY is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check SIBN's competition here
Varex Imaging Corporation (NASDAQ: VREX)
BFLY vs VREX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, VREX has a market cap of 779.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while VREX trades at $18.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas VREX's P/E ratio is 19.48. In terms of profitability, BFLY's ROE is -0.38%, compared to VREX's ROE of +0.05%. Regarding short-term risk, BFLY is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
BFLY vs SSII Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SSII has a market cap of 682.4M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SSII trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SSII's P/E ratio is -66.51. In terms of profitability, BFLY's ROE is -0.38%, compared to SSII's ROE of -0.27%. Regarding short-term risk, BFLY is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
BFLY vs SRDX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SRDX's P/E ratio is -34.66. In terms of profitability, BFLY's ROE is -0.38%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, BFLY is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
BFLY vs CTKB Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CTKB has a market cap of 607M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CTKB trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CTKB's P/E ratio is -24.90. In terms of profitability, BFLY's ROE is -0.38%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, BFLY is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CTKB's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
BFLY vs APEN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas APEN's P/E ratio is -9.43. In terms of profitability, BFLY's ROE is -0.38%, compared to APEN's ROE of -0.85%. Regarding short-term risk, BFLY is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
BFLY vs KIDS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, KIDS has a market cap of 575.6M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while KIDS trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas KIDS's P/E ratio is -18.99. In terms of profitability, BFLY's ROE is -0.38%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, BFLY is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
BFLY vs DCTH Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, DCTH has a market cap of 568.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while DCTH trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas DCTH's P/E ratio is 1648.00. In terms of profitability, BFLY's ROE is -0.38%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, BFLY is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
BFLY vs ZIMV Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, BFLY's ROE is -0.38%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, BFLY is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
BFLY vs CERS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CERS has a market cap of 521.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CERS trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CERS's P/E ratio is -51.70. In terms of profitability, BFLY's ROE is -0.38%, compared to CERS's ROE of -0.10%. Regarding short-term risk, BFLY is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
BFLY vs NPCE Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NPCE has a market cap of 508M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NPCE trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NPCE's P/E ratio is -26.14. In terms of profitability, BFLY's ROE is -0.38%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, BFLY is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check NPCE's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
BFLY vs TCMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, TCMD has a market cap of 493.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while TCMD trades at $21.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas TCMD's P/E ratio is 20.25. In terms of profitability, BFLY's ROE is -0.38%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, BFLY is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
BFLY vs SGHT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SGHT has a market cap of 454.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SGHT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SGHT's P/E ratio is -14.91. In terms of profitability, BFLY's ROE is -0.38%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, BFLY is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
BFLY vs CARL Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CARL has a market cap of 424.1M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CARL trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CARL's P/E ratio is -10.91. In terms of profitability, BFLY's ROE is -0.38%, compared to CARL's ROE of -0.38%. Regarding short-term risk, BFLY is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
BFLY vs PACB Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PACB has a market cap of 419.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PACB trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PACB's P/E ratio is -3.29. In terms of profitability, BFLY's ROE is -0.38%, compared to PACB's ROE of -49.62%. Regarding short-term risk, BFLY is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check PACB's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
BFLY vs CLPT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CLPT has a market cap of 418.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CLPT trades at $13.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CLPT's P/E ratio is -11.83. In terms of profitability, BFLY's ROE is -0.38%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, BFLY is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
BFLY vs SENS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SENS has a market cap of 402.5M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SENS trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SENS's P/E ratio is -4.32. In terms of profitability, BFLY's ROE is -0.38%, compared to SENS's ROE of -1.66%. Regarding short-term risk, BFLY is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
BFLY vs OFIX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, OFIX has a market cap of 375.5M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while OFIX trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas OFIX's P/E ratio is -6.05. In terms of profitability, BFLY's ROE is -0.38%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, BFLY is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
BFLY vs CATX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CATX has a market cap of 358.1M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CATX trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CATX's P/E ratio is -2.36. In terms of profitability, BFLY's ROE is -0.38%, compared to CATX's ROE of -0.42%. Regarding short-term risk, BFLY is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
BFLY vs TMCI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, TMCI has a market cap of 312M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while TMCI trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas TMCI's P/E ratio is -5.12. In terms of profitability, BFLY's ROE is -0.38%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, BFLY is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check TMCI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
BFLY vs SMLR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas SMLR's P/E ratio is 3.92. In terms of profitability, BFLY's ROE is -0.38%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, BFLY is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
BFLY vs TLSI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, TLSI has a market cap of 307.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while TLSI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas TLSI's P/E ratio is -2.98. In terms of profitability, BFLY's ROE is -0.38%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, BFLY is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
BFLY vs CV Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, CV has a market cap of 299.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while CV trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas CV's P/E ratio is -2.40. In terms of profitability, BFLY's ROE is -0.38%, compared to CV's ROE of -1.78%. Regarding short-term risk, BFLY is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
BFLY vs RCEL Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, RCEL has a market cap of 278.2M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while RCEL trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas RCEL's P/E ratio is -7.78. In terms of profitability, BFLY's ROE is -0.38%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, BFLY is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check RCEL's competition here
RxSight, Inc. (NASDAQ: RXST)
BFLY vs RXST Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, RXST has a market cap of 263.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while RXST trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas RXST's P/E ratio is -5.64. In terms of profitability, BFLY's ROE is -0.38%, compared to RXST's ROE of -0.17%. Regarding short-term risk, BFLY is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
BFLY vs PROF Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, PROF has a market cap of 250.4M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while PROF trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas PROF's P/E ratio is -7.03. In terms of profitability, BFLY's ROE is -0.38%, compared to PROF's ROE of -0.56%. Regarding short-term risk, BFLY is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
BFLY vs INFU Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, INFU has a market cap of 246M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while INFU trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas INFU's P/E ratio is 29.73. In terms of profitability, BFLY's ROE is -0.38%, compared to INFU's ROE of +0.15%. Regarding short-term risk, BFLY is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
BFLY vs MGRM Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas MGRM's P/E ratio is -12.00. In terms of profitability, BFLY's ROE is -0.38%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, BFLY is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
BFLY vs ELMD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ELMD has a market cap of 232.1M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ELMD trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ELMD's P/E ratio is 21.40. In terms of profitability, BFLY's ROE is -0.38%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, BFLY is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
BFLY vs NVRO Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas NVRO's P/E ratio is -1.91. In terms of profitability, BFLY's ROE is -0.38%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, BFLY is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
BFLY vs STIM Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, STIM has a market cap of 200.4M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while STIM trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas STIM's P/E ratio is -6.55. In terms of profitability, BFLY's ROE is -0.38%, compared to STIM's ROE of -1.51%. Regarding short-term risk, BFLY is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
BFLY vs BSGM Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas BSGM's P/E ratio is -5.81. In terms of profitability, BFLY's ROE is -0.38%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, BFLY is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
BFLY vs LUCD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, LUCD has a market cap of 179.2M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while LUCD trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas LUCD's P/E ratio is -2.54. In terms of profitability, BFLY's ROE is -0.38%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, BFLY is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
BFLY vs MDGS Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas MDGS's P/E ratio is -0.27. In terms of profitability, BFLY's ROE is -0.38%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, BFLY is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
BFLY vs QIPT Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas QIPT's P/E ratio is -15.87. In terms of profitability, BFLY's ROE is -0.38%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, BFLY is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
BFLY vs FOCL Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, FOCL has a market cap of 155.6M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while FOCL trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas FOCL's P/E ratio is -4.01. In terms of profitability, BFLY's ROE is -0.38%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, BFLY is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
BFLY vs QSI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, QSI has a market cap of 151.5M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while QSI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas QSI's P/E ratio is -1.67. In terms of profitability, BFLY's ROE is -0.38%, compared to QSI's ROE of -0.47%. Regarding short-term risk, BFLY is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
BFLY vs INGN Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, INGN has a market cap of 146.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while INGN trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas INGN's P/E ratio is -5.96. In terms of profitability, BFLY's ROE is -0.38%, compared to INGN's ROE of -0.13%. Regarding short-term risk, BFLY is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
BFLY vs QTRX Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, QTRX has a market cap of 126.7M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while QTRX trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas QTRX's P/E ratio is -1.06. In terms of profitability, BFLY's ROE is -0.38%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, BFLY is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
BFLY vs ICAD Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas ICAD's P/E ratio is -20.37. In terms of profitability, BFLY's ROE is -0.38%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, BFLY is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for BFLY.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
BFLY vs LNSR Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, LNSR has a market cap of 105.4M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while LNSR trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas LNSR's P/E ratio is 8.76. In terms of profitability, BFLY's ROE is -0.38%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, BFLY is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
BFLY vs HJLI Comparison September 2026
Butterfly Network, Inc. (NYSE: BFLY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BFLY stands at 2B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, BFLY is priced at $7.36 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BFLY currently has a P/E ratio of -30.67, whereas HJLI's P/E ratio is N/A. In terms of profitability, BFLY's ROE is -0.38%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, BFLY is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for BFLY.Check HJLI's competition here